Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma

Cited 8 time in webofscience Cited 0 time in scopus
  • Hit : 100
  • Download : 6
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder, affecting one in ten people aged over 65 years. Despite the severity of the disease, early diagnosis of AD is still challenging due to the low accuracy or high cost of neuropsychological tests and neuroimaging. Here we report clinically accurate and ultrasensitive detection of multiple AD core biomarkers (t-tau, p-tau(181), A beta(42), and A beta(40)) in human plasma using densely aligned carbon nanotubes (CNTs). The closely packed and unidirectionally aligned CNT sensor array exhibits high precision, sensitivity, and accuracy, evidenced by a low coefficient of variation (<6%), a femtomolar-level limit of detection, and a high degree of recovery (>93.0%). By measuring the levels of t-tau/A beta(42), p-tau(181)/A beta(42), and A beta(42)/A beta(40) in clinical blood samples, the sensor array successfully discriminates the clinically diagnosed AD patients from healthy controls with an average sensitivity of 90.0%, a selectivity of 90.0%, and an average accuracy of 88.6%.
Publisher
NATURE PUBLISHING GROUP
Issue Date
2020-01
Language
English
Article Type
Article
Citation

NATURE COMMUNICATIONS, v.11

ISSN
2041-1723
DOI
10.1038/s41467-019-13901-z
URI
http://hdl.handle.net/10203/272426
Appears in Collection
MS-Journal Papers(저널논문)
Files in This Item
000512536000009.pdf(1.09 MB)Download
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 8 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0